Below are the most recent publications written about "Diarrhea" by people in Profiles.
-
Saulino DM, Chandran A, Ambelil M, Al Salihi S, Conyers J, Ertan A, DuPont AW, Cash BD, Younes M. Colonic Eosinophilia: Clinicopathologic Study of Paired Right and Left Colon Biopsies from 276 Patients. Ann Clin Lab Sci. 2023 Jan; 53(1):76-81.
-
Bedard PL, Li S, Wisinski KB, Yang ES, Limaye SA, Mitchell EP, Zwiebel JA, Moscow JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT. Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B. JCO Precis Oncol. 2022 07; 6:e2200165.
-
Nwachuku E, Shan Y, Senthil-Kumar P, Braun T, Shadis R, Kirton O, Vu TQ. Toxic Clostridioides (formerly Clostridium) difficile colitis: No longer a diarrhea associated infection. Am J Surg. 2021 01; 221(1):240-242.
-
Kambhampati S, Bauer KE, Bracci PM, Keenan BP, Behr SC, Gordan JD, Kelley RK. Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer. 2019 09 15; 125(18):3234-3241.
-
Mehnert JM, Varga A, Brose MS, Aggarwal RR, Lin CC, Prawira A, de Braud F, Tamura K, Doi T, Piha-Paul SA, Gilbert J, Saraf S, Thanigaimani P, Cheng JD, Keam B. Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer. BMC Cancer. 2019 Mar 04; 19(1):196.
-
Thulasi V, Steer RA, Monteiro IM, Ming X. Overall severities of gastrointestinal symptoms in pediatric outpatients with and without autism spectrum disorder. Autism. 2019 02; 23(2):524-530.
-
Gallo A, Vallone C, Sabatelli L, Ventura G, Covino M, Cammarota G, Gasbarrini A, Landolfi R, Montalto M. Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. Scand J Gastroenterol. 2018 05; 53(5):567-572.
-
Schwebke JR, Morgan FG, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Am J Obstet Gynecol. 2017 12; 217(6):678.e1-678.e9.
-
Lee GO, Richard SA, Kang G, Houpt ER, Seidman JC, Pendergast LL, Bhutta ZA, Ahmed T, Mduma ER, Lima AA, Bessong P, Jennifer MS, Hossain MI, Chandyo RK, Nyathi E, Lima IF, Pascal J, Soofi S, Ladaporn B, Guerrant RL, Caulfield LE, Black RE, Kosek MN. A Comparison of Diarrheal Severity Scores in the MAL-ED Multisite Community-Based Cohort Study. J Pediatr Gastroenterol Nutr. 2016 11; 63(5):466-473.
-
Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol. 2016 Aug 28; 22(32):7186-202.